Dr. Alan Dosik, MD

Dr. Dosik practices at Dosik Hematology and Oncology in Brooklyn, New York.

Dr. Dosik's NPI, 1528010386, was assigned on May 17, 2006. Dr. Dosik graduated from SUNY Downstate Health Sciences University in 1997. Dr. Dosik holds New York license 210889.

Dr. Dosik's primary practice is Dosik Hematology and Oncology, at 500 4th Avenue, Suite 1, Brooklyn, NY 11215. The practice phone is (718) 208-1820.

Dr. Dosik's primary practice is Dosik Hematology and Oncology in Brooklyn, New York. Dr. Dosik is also affiliated with Maimonides Medical Center. The medical group on file is Dosik Hematology & Oncology. Dmand AI also links Dr. Dosik to 2 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Dosik's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dosik practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Dosik's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Dosik is board certified in hematology by the American Board of Internal Medicine. Dr. Dosik is licensed in New York.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer and lymphoma among the conditions Dr. Dosik treats.

CMS data shows 40,921 Medicare services from Dr. Dosik across 24 procedure codes in 2024, for 476 Medicare patients. Medicare paid $439,788 for them. Every service was in an office.

CMS counts 476 Medicare patients who saw Dr. Dosik in 2024. The largest group is 75 to 84, with 197 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dosik's median patient age at 68, with 69% women.

In 2024, Dr. Dosik wrote 1,156 Medicare Part D claims for 245 patients. 84% of them were for generic drugs. CMS names the drug for 1,061 of them, across 17 drugs with 11 or more claims each, at $1,308,188 in total drug cost. In 2023, CMS named 1,261 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Dosik for performance year 2024, reported through an alternative payment model (APM). Dr. Dosik accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dosik as offering telehealth.

Dmand AI links 2 papers to Dr. Dosik. Dr. Dosik's most frequent co-authors are Richard R. Furman, MD, John P. Leonard, MD and Ruben Niesvizky, MD.

CMS Open Payments shows 748 general payments to Dr. Dosik from 86 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,326.

Dr. Dosik graduated from SUNY Downstate Health Sciences University in 1997. Dr. Dosik is a member of ASCO.

Dr. Dosik is in network with 14 carriers, including Aetna, United Healthcare and Alliant Health Plans. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.